ACET Price / Book | Adicet Bio, Inc.

Adicet Bio, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Adicet Bio, Inc. price/book ratio for the quarter ending 2026-06-30 was 0.67, a 72.53% increase year-over-year.
Adicet Bio, Inc. price/book ratio for the quarter ending 2026-03-31 was 0.47, a 92.46% decline year-over-year.
Adicet Bio, Inc. price/book ratio for the quarter ending 2025-12-31 was 0.51, a 18.97% increase year-over-year.
Adicet Bio, Inc. price/book ratio for the quarter ending 2025-09-30 was 0.62, a 93.09% decline year-over-year.
Adicet Bio, Inc. price/book ratio for fiscal 2026 was 0.67.
Adicet Bio, Inc. price/book ratio for fiscal 2025 was 0.51, a 18.97% increase from fiscal 2024.
Adicet Bio, Inc. price/book ratio for fiscal 2024 was 0.43, a 94.46% decline from fiscal 2023.
Adicet Bio, Inc. price/book ratio for fiscal 2023 was 7.69, a 63.42% decline from fiscal 2022.

Available history: 2018-03-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.67	$80.32M	$120.14M
2026-03-31	0.47	$65.36M	$140.07M
2025-12-31	0.51	$80.62M	$159.21M
2025-09-30	0.62	$67.69M	$109.14M
2025-06-30	0.39	$51.68M	$133.37M
2025-03-31	6.19	$999.13M	$161.45M
2024-12-31	0.43	$79.43M	$186.61M
2024-09-30	8.98	$1.9B	$211.53M
2024-06-30	6.79	$1.6B	$235.11M
2024-03-31	11.94	$3.09B	$258.8M
2023-12-31	7.69	$1.31B	$170.18M
2023-09-30	4.85	$944.93M	$194.68M
2023-06-30	7	$1.67B	$239.06M
2023-03-31	14.87	$3.96B	$266.22M
2022-12-31	21.02	$6.14B	$292.34M
2022-09-30	30.65	$9.74B	$317.66M
2022-06-30	31.88	$9.35B	$293.27M
2022-03-31	40.96	$12.74B	$311.08M
2021-12-31	36.68	$11.12B	$303.13M
2021-09-30	23.03	$5B	$217.22M
2021-06-30	22.96	$5.24B	$228.34M
2021-03-31	28.17	$6.66B	$236.26M
2020-12-31	81.34	$8.93B	$109.83M
2020-09-30	31.87	$3.73B	$116.93M
2020-06-30	-121.16	$8.78B	-$72.43M
2020-03-31	-65.16	$4.2B	-$64.53M
2019-12-31	-5.96	$359.72M	-$60.37M
2019-09-30	-666.59	$36.08B	-$54.13M
2019-06-30	-1,029.51	$40.92B	-$39.75M
2019-03-31	-721.54	$26.93B	-$37.32M
2018-12-31	-808.14	$27.09B	-$33.52M
2018-09-30	434.98	$47.56B	$109.34M
2018-06-30	245.33	$28.74B	$117.16M
2018-03-31	230.8	$30.09B	$130.38M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.67	$80.32M	$120.14M
2025-12-31	0.51	$80.62M	$159.21M
2024-12-31	0.43	$79.43M	$186.61M
2023-12-31	7.69	$1.31B	$170.18M
2022-12-31	21.02	$6.14B	$292.34M
2021-12-31	36.68	$11.12B	$303.13M
2020-12-31	81.34	$8.93B	$109.83M
2019-12-31	-5.96	$359.72M	-$60.37M
2018-12-31	-808.14	$27.09B	-$33.52M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Valion Bio, Inc. (VBIO)	United States	$0.077B
Lifevantage Corp (LFVN)	United States	$0.078B	15.40
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41